Skip to main navigation Skip to search Skip to main content

Integrated safety analysis of umbralisib, a dual PI3Kd/CK1« inhibitor, in relapsed/refractory lymphoid malignancies

  • Matthew S. Davids
  • , Owen A. O’Connor
  • , Wojciech Jurczak
  • , Felipe Samaniego
  • , Timothy S. Fenske
  • , Pier Luigi Zinzani
  • , Manish R. Patel
  • , Nilanjan Ghosh
  • , Bruce D. Cheson
  • , Enrico Derenzini
  • , Danielle M. Brander
  • , James A. Reeves
  • , Wanda Knopinska-Posłuszny
  • , John N. Allan
  • , Tycel Phillips
  • , Paolo F. Caimi
  • , Ewa Lech-Maranda
  • , John M. Burke
  • , Richy Agajanian
  • , Ruth Pettengell
    • Lori A. Leslie, Chan Y. Cheah, Gustavo Fonseca, James Essell, Julio C. Chavez, John M. Pagel, Jeff P. Sharman, Yanzhi Hsu, Hari P. Miskin, Peter Sportelli, Michael S. Weiss, Ian W. Flinn

Research output: Contribution to journal › Article › peer-review

23   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Integrated safety analysis of umbralisib, a dual PI3Kd/CK1« inhibitor, in relapsed/refractory lymphoid malignancies'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry